Michael F. Cannon Pharmaceutical giant Merck is suing Medicare, claiming new drug‐pricing reforms that Congress enacted in last year’s Inflation...
Read moreJack Solowey and Jennifer J. Schulp While the Securities and Exchange Commission (SEC) leans into regulating crypto by enforcement, lawmakers...
Read moreClark Neily Reports that Donald Trump has been indicted on federal charges of mishandling classified documents, obstruction of justice, and...
Read moreColleen Hroncich Oklahoma parents will soon have an easier time affording the educational options that work best for their children....
Read moreWalter Olson In a long line of cases on race and redistricting, the Supreme Court has generally ruled that some race‐conscious...
Read moreThomas A. Berry In 2020, Netflix began streaming the French film Cuties. The film follows an 11‐year‐old Senegalese immigrant, Amy,...
Read moreNeal McCluskey In Iowa, Holy Family Catholic Schools announced that they would be raising prices 10 to 40 percent, depending...
Read moreJeffrey A. Singer I have written often about the so‐called Iron Law of Prohibition: “The harder the law enforcement, the...
Read morePatrick G. Eddington I think it’s fair to question whether or not the current House Oversight Committee inquiry into allegations...
Read moreAdam N. Michel and Scott Lincicome In the last few years, Congress has authorized as much as $2.1 trillion in...
Read moreDisclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 TopStocksInsider. All Rights Reserved.